From: Borderline ovarian tumors: clinical characteristics, management, and outcomes - a multicenter study
Age | |
Median (n, range in years) | 41.2 (16–82) |
< 40 years (n, %) | 353 (48.2) |
≥ 40 years (n, %) | 380 (51.8) |
Postmenopausal status (n, %) | 227 (31.0) |
Histology | |
Serous (n, %) | 534 (72.9) |
Mucinous (n, %) | 160 (21.8) |
Other (n, %) | 39 (5.3) |
Ultrasound image | |
Solid (n, %) | 110 (15.0) |
Cystic (n, %) | 130 (17.7) |
Unknown (n, %) | 493 (67.3) |
Median CA-125 level (U/mL) | 89 (1–3394) |
Median size (mm) | 112.02 ± 64.57 |
Stage in diagnosis (n, %) | |
IA | 516 (70.4) |
IB | 74 (10.1) |
IC | 64 (8.7) |
IIA | 2 (0.3) |
IIB | 6 (0.8) |
IIC | 8 (1.1) |
IIIA | 0 |
IIIB | 11 (1.5) |
IIIC | 52 (7.1) |
IV | 0 |
Disease-free survival (n, range in months) | 51.7 (1–216) |
Overall survival (n, range in months) | 55.2 (1–216) |
Duration of follow-up (n, range in months) | 55.2 (1–216) |